Topokine therapeutics
WebFeb 9, 2024 · Assignee: Topokine Therapeutics, Inc. Inventors: Michael S. Singer, Murat V. Kalayoglu Methods and compositions for topical delivery of prostaglandins to … WebExplore {Topokine Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Topokine …
Topokine therapeutics
Did you know?
WebApr 22, 2016 · Allergan has acquired Topokine Therapeutics for an upfront payment of $85 million and success-based development and sales milestones for XAF5. Topokine is a … WebMar 17, 2015 · Michael Singer and Murat Kalayoglu ran the study that had the accidental results and thus launched Topokine Therapeutics. They are PhDs and opthamologists, so it would stand to reason that they ...
WebApr 22, 2016 · Allergan has acquired Topokine Therapeutics for an upfront payment of $85 million and success-based development and sales milestones for XAF5. Topokine is a privately held, clinical-stage biotechnology company focused on developing topical medicines for fat reduction. XAF5 is a first-in-class topical agent in late-stage … WebApr 28, 2016 · Apr 28th, 2016. Allergan has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company focused on developing topical medicines for …
WebApr 22, 2016 · Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company focused on developing topical medicines for fat reduction. Under the terms of the agreement, Allergan acquired Topokine Therapeutics for an upfront … WebTopokine Therapeutics is a clinical-stage biotechnology company developing therapies for dermatology and medical aesthetics. The company's lead program, XAF5 Gel, is a skin …
WebTopokine Therapeutics is a clinical-stage biotechnology company developing therapies for dermatology and medical aesthetics. The company's lead program, XAF5 Gel, is a skin cream being developed for local reduction of excess subcutaneous fat. XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor ...
WebNov 21, 2013 · Topokine Therapeutics: More Information. Go to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information. Layout table for additonal information; Responsible Party: Topokine Therapeutics, Inc. ClinicalTrials.gov Identifier: golf shop isle of wightWebApr 22, 2016 · Allergan has acquired Topokine Therapeutics for $85 million upfront in a deal that expands the buyer’s cosmetic drugs pipeline with Topokine’s Phase IIb/III candidate … golf shop jacksonville ncWebJan 5, 2024 · April 21, 2016: Allergan announced the acquisition of Topokine Therapeutics for an upfront payment of $85 million plus potential milestones. Topokine's lead assets is XAF5, a first-in-class ... golf shop jackson msWebMar 12, 2013 · Topokine Therapeutics is a clinical-stage biotechnology company developing therapies for dermatology and medical aesthetics. The company's lead program, XAF5 … health break phWebJan 5, 2016 · NEW YORK, NY and CHARLOTTE, NC – Global alternative asset manager The Carlyle Group (NASDAQ: CG) announced today that it has formed a joint venture with … golf shop jerseyWebTopokine Therapeutics president and CEO Murat Kalayoglu said, "This exclusive license further enhances our IP position, and we are excited to collaborate with him and the University of Bristol." Topokine’s lead program, XAF5 Gel, is a skin cream being developed for local reduction of excess subcutaneous fat. healthbreak providence missoulaWebTopokine Therapeutics, Inc. operates as a clinical-stage biotechnology company. The Company develops non-invasive therapies for dermatology and medical aesthetics, such as a topical product for ... health break news